| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-14 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.31 | 2e-12 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-12 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.29 | 9e-12 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-10 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-10 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-10 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-10 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.32 | 4e-10 |